Live Breaking News & Updates on Dystrogen Therapeutics Corp

Stay updated with breaking news from Dystrogen therapeutics corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dystrogen Therapeutics Investigational Chimeric Cell Therapy DT-DEC01 for Duchenne Muscular Dystrophy Demonstrates Clinically Significant Functional and Biomarker Improvements

Results continue to support evidence for safety, tolerability, clinical efficacy, and biomarker improvements of DT-DEC01 At 6 months treated patients achieved. ....

United States , Kris Siemionow , Dystrogen Therapeutics Corp , Dystrogen Therapeutics Corporation ,

Dystrogen Therapeutics Investigational Chimeric Cell Therapy DT-DEC01 for the Treatment of Duchene Muscular Dystrophy Shows Safety and Functional Improvements

/PRNewswire/ Dystrogen Therapeutics, Corp. the leader in chimeric cell therapies, today announced positive results from an ongoing study conducted in Poland. ....

United States , Maria Siemionow , Dystrogen Therapeutics Corp , Dystrogen Therapeutics Corporation , Chief Scientific Officer , Safety Monitoring Board , Professor Siemionow , Dystrophin Expressing Chimeric , Advanced Therapy Medicinal Products , Using Dystrogen ,